LktA deletion mutant of P. haemolytica

Details LktA deletion mutant of P. haemolytica LktA deletion mutant of P. haemolytica

2005-08-30

2005-08-30

Graser, Jennifer E. (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S234100, C424S172100, C424S252100, C424S439000, C424S442000, C424S193100, C435S069100, C435S320100, C530S350000

Reexamination Certificate

active

06936262

ABSTRACT:
Mutants ofP. haemolyticaprovide excellent safety and efficacy when used as vaccines in ruminants, for example cattle, sheep, and goats, subject to pneumonic pasteurellosis. They can be administered by a variety of routes. Especially preferred is the use in animal feeds. The mutants are not reverting and contain no foreign DNA and no introduced antibiotic resistance genes.

REFERENCES:
patent: 5422110 (1995-06-01), Potter et al.
patent: 5476657 (1995-12-01), Potter
patent: 5733780 (1998-03-01), Briggs et al.
patent: WO 97 16531 (1997-05-01), None
patent: 97/41823 (1997-11-01), None
George L. Murphy et al. “Hemolytic Activity of thePasteurella haemolyticaLeukotoxin” Infection and Immunity, Aug. 1995, pp. 3209-3212.
Natalie D. Fedorova & Sarah K. Highlander “Generation of Targeted Nonpolar Gene Insertions and Operon Fusions inPasteurella haemolyticaand Creation of a Strain that Produces and Secretes Inactive Leukotoxin” Infection and Immunity, Jul. 1997, pp. 2593-2598.
Fred M. Tatum et al. “Construction of an isogenic leukotoxin deletion mutant ofPasteurellahaemolytica serotype 1: characterization and virulence” Microbial Pathagenesis 1998; 24:37-46.
Robert E. Briggs et al. “Development and testing of a unique strain ofPasteurellahaemolytica for use in studies on colonization of the respitory tract of cattle” AJVR, vol. 59, No. 4, Apr. 1998.
Robert E. Briggs et al. “Rapid spread of a unique strain ofPasteurella haemolyticaserotype 1 among transported calves” AJVR, vol. 59, No. 4, Apr. 1998.
Glynn H. Frank et al. “Colonization of the tonsils and nasopharynx of calves by a rifampicin-resistantPasteurella haemolyticaand its inhibition by vaccination” Am J Vet Res., vol. 56, No. 7, Jul. 1995.
G.H. Frank et al. “Serotype-specific inhibition of colonization of the tonsils and nasopharynx of calves afterPasteurella haemolyticaserotype A1 after vaccination with the organism” Am J Vet Res, vol. 55, No. 8, Aug. 1994.
G.H. Frank & R.E. Briggs “Colonization of the tonsils of calves withPasteurella haemolytica”Am J Vet Res, vol. 53, No. 4, Apr. 1992.
Glynn H. Frank “Infection of the middle nasal meatus of calves withPasteurella haemolyticaserotype 1”Am J Vet Res, vol. 50, No. 8, Aug. 1989.
David C. Straus et al. “In Vivo Production of Neuraminidase byPasteurella haemolyticain Market Stressed Cattle After Natural Infection” Current Microbiology, vol. 37 (1998) pp. 240-244.
Glynn H. Frank et al. “Respiratory tract disease and mucosal colonization byPasteurella haemolyticain transported cattle” AJVR, vol. 57, No. 9, Sep. 1996 pp. 1317-1320.
Cruz W.T. et al. “Deletion analysis resolves cell-binding and lytic domains of the Pasteurelle leutoxn” Molecular Microbiology, vol. 4, No. 11, Nov. 1990, pp. 1933-1939.
Petras S.F. et al. “Antigenic and virulence properties of Pasteurella haemolytica leukotoxin mutants” Infection and Immunity, vol. 63, No. 5, Mar. 1995, pp. 1033-1039.
Homchampa et al. “Cross protective immunity conferred by a marker-freearo Amutant ofPasteurella multocida”Vaccine 1997, vol. 15, No. 2.
Beaumont et al. “Identification and characterization ofalR, a Gene Encoding an AraC-Like Regulator of Alcaligin Siderophore Biosynthesis and Transport inBordetellaρpertussisandBordetella bronchiseptica”Journal of Bacteriology, Feb. 1998, pp. 862-870, vol. 180, No. 4.
Link et al. “Methods for Generating Precise Deltions and Insertions in the Genome of Wild-TypeEscherichia coli:Application to Open Reading Frame Characterization” Journal of Bacteriology, Oct. 1997, pp. 628-6237, vol. 179, No. 20.
Cotter and Miller “BvgAS-Medicated Signal Transduction: Analysis of Phase-Locked Regulatory Mutants ofBordetella bronchisepticain a Rabbit Model” Infection and Immunity Aug. 1994, pp. 3381-3390, vol. 62, No. 8.
Hamilton et al. “New Method for Generating Deletions and Gene Replacements inEscherichia coli”Journal of Bacteriology, Sep. 1989, pp. 4617-4622, vol. 171, No. 9.
Murphy G.L. et al. “Haemolytic activity of the Pasteurella haemolytica leukotoxin” Infection and Immunity, vol. 63, No. 8, Aug. 1995, pp. 3209-3212.
Cruz W.T. et al. “Deletion analysis resolves cell-binding and lytic domains of the Pasteurella leukotoxin” Molecular Microbiology, vol. 4, No. 11, Nov. 1990, pp. 1933-1939.
Petras S.F. et al. “Antigenic and virulence properties of Pasteurella haemolytica leukotoxin mutants” Infection and Immunity, vol. 63, No. 5, Mar. 1995, pp. 1033-1039.
Boslego et al., “Gonorrhea Vaccines”, Vaccines and Immunotherapy, 1991, pp. 211-233, Chapter 17.

Affiliated with

Also associated with

Rating

LktA deletion mutant of P. haemolytica does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with LktA deletion mutant of P. haemolytica, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and LktA deletion mutant of P. haemolytica will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3501378